Predict which psychedelics are right for you

Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform

Ketamine therapy for depression seems promising, but how do you know if it’s right for you?

About 30% of people have a genetic variant that impairs the secretion of BDNF, a protein that promotes the growth of neurons.

Since ketamine works by increasing the release of BDNF, people with this gene variant may have a decreased response to the antidepressant effects of ketamine therapy.

HaluGen just expanded its Psychedelics Genetic Test Kit to test for the gene variant! It also tells you how sensitive you’re to classical psychedelics and if you are at risk for schizophrenia, bipolar disorder, or psychosis.

Use code “DAILYMUSHROOM” to get 10% off HaluGen’s Psychedelics Genetic Test!

Entheon’s psychedelics genetic test kit developed now available in Canada

Entheon Biomedical Corp. Launches HaluGen’s Psychedelics Genetic Test

Entheon Biomedical Corp. launched the first psychedelics genetic test kit through its subsidiary, HaluGen Life Sciences Inc. The kit includes a pre-screening mental health survey and cheek swab DNA test that will provide “genetic, personal and familial insights” to “better understand an individual’s sensitivity to classical psychedelics and ketamine”. The cheek swab tests for the HTR2A gene mutation,  a variant present in 20% of people that makes them more susceptible to strong hallucinations due to increased serotonin receptor density. Customers receive a personalized profile with sensitivity and risk reports to inform them before their next psychedelic experience.

PDF of article